Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

55.29
Delayed Data
As of 3:55pm ET
 +0.335 / +0.61%
Today’s Change
45.69
Today|||52-Week Range
63.62
-2.65%
Year-to-Date

Today’s Trading

Previous close54.95
Today’s open54.78
Day’s range54.59 - 55.40
Volume10,321,686
Average volume (3 months)10,058,341
Market cap$154.8B
Dividend yield3.26%
Data as of 3:55pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+176.87%
Earnings growth (this year)+0.58%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)-4.48%
P/E ratio16.2
Price/Sales3.95
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.54-1.08%
AGNAllergan-4.90-1.57%
NVONovo Nordisk-0.49-0.87%
ABBVAbbVie-0.68-1.05%
Data as of 3:55pm ET, 08/28/2015

Financials

Next reporting dateOctober 26, 2015
EPS forecast (this quarter)$0.92
Annual revenue (last year)$42.1B
Annual profit (last year)$11.9B
Net profit margin28.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers